Capital Wealth Alliance’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,982
Closed -$4.08M 74
2024
Q4
$4.08M Hold
22,982
2.31% 11
2024
Q3
$4.54M Sell
22,982
-90
-0.4% -$16.8K 2.64% 10
2024
Q2
$3.96M Buy
23,072
+1
+0% +$166 2.26% 11
2024
Q1
$4.2M Buy
23,071
+1
+0% +$172 2.48% 9
2023
Q4
$3.58M Sell
23,070
-36
-0.2% -$5.25K 2.45% 9
2023
Q3
$3.44M Buy
23,106
+1
+0% +$147 2.59% 10
2023
Q2
$3.11M Buy
23,105
+1
+0% +$147 2.34% 8
2023
Q1
$3.68M Sell
23,104
-293
-1% -$44.8K 2.97% 4
2022
Q4
$3.78M Sell
23,397
-756
-3% -$116K 3.17% 5
2022
Q3
$3.24M Buy
24,153
+1
+0% +$143 2.69% 7
2022
Q2
$3.7M Sell
24,152
-3
-0% -$458 2.59% 7
2022
Q1
$3.92M Sell
24,155
-7
-0% -$1.02K 2.33% 11
2021
Q4
$3.27M Sell
24,162
-20
-0.1% -$2.36K 1.91% 9
2021
Q3
$2.64M Buy
24,182
+1
+0% +$114 1.61% 13
2021
Q2
$2.79M Sell
24,181
-50
-0.2% -$5.63K 1.78% 11
2021
Q1
$2.62M Buy
24,231
+759
+3% +$81.2K 1.75% 12
2020
Q4
$2.43M Buy
23,472
+43
+0.2% +$4.13K 1.78% 14
2020
Q3
$2.05M Buy
23,429
+109
+0.5% +$10.3K 1.85% 13
2020
Q2
$2.29M Sell
23,320
-1,578
-6% -$139K 2.38% 11
2020
Q1
$1.9M Sell
24,898
-20
-0.1% -$1.7K 1.98% 10
2019
Q4
$2.02M Buy
+24,918
New +$2.07M 1.68% 15

Other funds holding ABBV

Capital Wealth Alliance's ABBV Position: Q1 2025 in Review

Capital Wealth Alliance sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 22,982 shares — an estimated $4.08M sold.

Capital Wealth Alliance first reported a position in ABBV in Q4 2019 and held it in 21 quarters. The position peaked at $4.54M in Q3 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Capital Wealth Alliance reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Capital Wealth Alliance sold 22,982 AbbVie shares in Q1 2025, an estimated $4.08M.
  • Capital Wealth Alliance first reported a position in AbbVie in Q4 2019 and held it in 21 quarters.
  • Capital Wealth Alliance's AbbVie position peaked at $4.54M in Q3 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Capital Wealth Alliance's 13F filing for Q1 2025, filed 14 May 2025.